120 related articles for article (PubMed ID: 3316159)
21. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of Staphylococcus aureus bacteraemia.
Mitchell DH; Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
[TBL] [Abstract][Full Text] [Related]
23. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
[TBL] [Abstract][Full Text] [Related]
24. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users.
DiNubile MJ
Ann Intern Med; 1994 Dec; 121(11):873-6. PubMed ID: 7978701
[TBL] [Abstract][Full Text] [Related]
25. Combination antibiotic therapy in prosthetic endocarditis due to Staphylococcus epidermidis.
Shainhouse JZ
Can Med Assoc J; 1978 Sep; 119(6):556-8. PubMed ID: 709444
[No Abstract] [Full Text] [Related]
26. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
27. [Endocarditis caused by Staphylococcus aureus in drug addicts and non-addicts: the same microbe in 2 diseases].
Verdejo C; Fernández Guerrero ML; Castrillo JM; Fernández Clúa MA; Díaz Curiel M; de Villalobos E
Rev Clin Esp; 1989; 185(3):123-7. PubMed ID: 2623224
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin.
Watanakunakorn C; Baird IM
Am J Med Sci; 1977; 273(2):133-9. PubMed ID: 871133
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
30. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations.
Karchmer AW
J Antimicrob Chemother; 1988 Apr; 21 Suppl C():91-106. PubMed ID: 3290187
[TBL] [Abstract][Full Text] [Related]
32. The role of vancomycin in the treatment paradigm.
Stevens DL
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
[TBL] [Abstract][Full Text] [Related]
33. Staphylococcal infective endocarditis.
Thompson RL
Mayo Clin Proc; 1982 Feb; 57(2):106-14. PubMed ID: 7033683
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic treatment of infective endocarditis.
Wilson WR; Geraci JE
Annu Rev Med; 1983; 34():413-27. PubMed ID: 6344769
[TBL] [Abstract][Full Text] [Related]
35. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
36. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
Galetto DW; Boscia JA; Kobasa WD; Kaye D
J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
[TBL] [Abstract][Full Text] [Related]
37. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
[TBL] [Abstract][Full Text] [Related]
38. [An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].
Enia F; Bella R; Mineo R; Mizio G; Reina G
Ital Heart J Suppl; 2005 Mar; 6(3):121-7. PubMed ID: 15875497
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report.
Saravu K; Mukhopadhyay C; Satyanarayanan V; Pai A; Komaranchath AS; Munim F; Shastry BA; Tom D
Scand J Infect Dis; 2012 Jul; 44(7):544-7. PubMed ID: 22385220
[TBL] [Abstract][Full Text] [Related]
40. Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations.
Whitener C; Caputo GM; Weitekamp MR; Karchmer AW
Infect Dis Clin North Am; 1993 Mar; 7(1):81-96. PubMed ID: 8463655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
